Drug Shortage Report for PRIVA-ROSUVASTATIN
Report ID | 78960 |
Drug Identification Number | 02445433 |
Brand name | PRIVA-ROSUVASTATIN |
Common or Proper name | ROSUVASTATIN |
Company Name | PHARMAPAR INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | ROSUVASTATIN |
Strength(s) | 20MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | C10AA |
ATC description | LIPID MODIFYING AGENTS, PLAIN |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2019-03-19 |
Actual start date | 2019-03-19 |
Estimated end date | Unknown |
Actual end date | 2021-09-01 |
Shortage status | Resolved |
Updated date | 2021-10-15 |
Company comments | choix de l'entreprise |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1565 BOUL LIONEL-BOULET VARENNES, QUEBEC CANADA J3X 1P7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2019-03-20 | English | Compare |
v2 | 2019-03-20 | French | Compare |
v3 | 2021-10-15 | English | Compare |
v4 | 2021-10-15 | French | Compare |
Showing 1 to 4 of 4